Quick Screen

Our ‘quick’ screen program allows companies to obtain a preliminary dataset in a cost-effective manner. We leverage a combination of our cell and assay platforms in designing assays that can help address important questions in drug screening. These assays are offered on a weekly basis for a fixed fee/fixed readout.

Integrated Studies

To maintain continuity, we can study our cells and assay platforms in a synergistic manner across multiple assay platforms. The data generated across various platform using a common cell line allows cross comparison of the various factors that maybe involved in a drug’s mechanism of action or function.

Partnerships

We seek partnerships with companies with similar interests of changing the paradigm of drug development. We welcome conversations that help us think outside the box and where we can leverage our expertise, tools, capabilities and platforms for advancing research and development.

HOW CAN WE WORK WITH YOU?

null

OUTSOURCE

For partners with limited resources, our team can help pull together the “tools” necessary to screen your drug candidates.
null

CONFIRM

Have you generated internal results? Let us independently confirm your results with our cell platforms.
null

PARTNERSHIP

For virtual biotechs – we think alike. We know the meaning of being capital efficiency. Let us handle your IO translational work.

Our capabilities

Our infrastructure is equipped with state-of-the-art equipment necessary to conduct any preclinical research studies.

Leadership

Our team has a history of working together and we bring a collective
expertise in helping our clients achieve their goals.

[mc4wp_form id=”200″]